SGK
ABBV icon

Steigerwald Gordon & Koch’s AbbVie ABBV Stock Holding History

Steigerwald Gordon & Koch’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$823K Buy
3,270
+71
+2% +$15.3K 0.08% 72
2026
Q1 		$696K Sell
3,199
-48
-1% -$10.6K 0.07% 74
2025
Q4 		$742K Sell
3,247
-2
-0.1% -$456 0.07% 80
2025
Q3 		$752K Sell
3,249
-34
-1% -$6.92K 0.07% 79
2025
Q2 		$609K Sell
3,283
-78
-2% -$14.5K 0.06% 75
2025
Q1 		$704K Buy
3,361
+123
+4% +$23.9K 0.08% 71
2024
Q4 		$575K Sell
3,238
-107
-3% -$19.7K 0.07% 81
2024
Q3 		$661K Buy
3,345
+101
+3% +$18.9K 0.07% 77
2024
Q2 		$556K Buy
3,244
+150
+5% +$24.8K 0.07% 79
2024
Q1 		$563K Buy
3,094
+163
+6% +$28.1K 0.07% 78
2023
Q4 		$454K Sell
2,931
-123
-4% -$17.9K 0.06% 83
2023
Q3 		$455K Buy
3,054
+757
+33% +$111K 0.07% 79
2023
Q2 		$310K Buy
2,297
+63
+3% +$9.24K 0.05% 89
2023
Q1 		$356K Sell
2,234
-4
-0.2% -$612 0.05% 84
2022
Q4 		$362K Buy
2,238
+167
+8% +$25.6K 0.06% 85
2022
Q3 		$278K Buy
2,071
+37
+2% +$5.31K 0.05% 87
2022
Q2 		$312K Sell
2,034
-66
-3% -$10.1K 0.05% 88
2022
Q1 		$340K Sell
2,100
-14
-0.7% -$2.03K 0.05% 91
2021
Q4 		$286K Buy
2,114
+8
+0.4% +$945 0.04% 94
2021
Q3 		$227K Buy
2,106
+42
+2% +$4.8K 0.04% 106
2021
Q2 		$233K Hold
2,064
– – 0.04% 101
2021
Q1 		$223K Sell
2,064
-49
-2% -$5.24K 0.04% 100
2020
Q4 		$226K Sell
2,113
-173
-8% -$16.6K 0.05% 98
2020
Q3 		$200K Buy
2,286
+140
+7% +$13.2K 0.05% 96
2020
Q2 		$211K Buy
+2,146
New +$189K 0.06% 91

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steigerwald Gordon & Koch's ABBV Position: Q2 2026 in Review

Steigerwald Gordon & Koch increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $15.3K and bringing the position to 3,270 shares worth $823K. The position accounts for 0.08% of the portfolio, ranked #72.

Steigerwald Gordon & Koch first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Steigerwald Gordon & Koch held 3,270 shares of AbbVie worth $823K as of Q2 2026.
  • Steigerwald Gordon & Koch bought 71 AbbVie shares in Q2 2026, an estimated $15.3K.
  • AbbVie made up 0.08% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #72 holding.
  • Steigerwald Gordon & Koch first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.